Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
atorvastatin (lipitor) (1 trial)
bone morphogenetic protein-2 (1 trial)
Retroperitoneal Fibrosis (Phase 4)
Trials (1 total)
Trial APIs (2 total)